EOLS FY 2017 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$218,000

Operating Income

-$12M

Net Income

-$4M

EPS (Diluted)

$-0.19

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$586,000

Balance Sheet

Total Assets

$152M

Total Liabilities

$228M

Stockholders' Equity

-$76M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$218,000	-$326,000	+33.1%
Operating Income	-$12M	-$20M	+41.3%
Net Income	-$4M	-$20M	+77.7%